Wednesday, August 27, 2025
StockstToday.com Logo
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Needham Analyst Reiterates Buy Rating and 28 Price Target for Liquidia Technologies

Elaine Mendonca by Elaine Mendonca
March 13, 2024
in Breaking News
0
Biotechnology Trading online
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Needham analyst Serge Belanger has reiterated his Buy rating and $28 price target for Liquidia (NASDAQ:LQDA) on March 13, 2024. This reaffirmation underscores his optimistic view on the company’s future performance and growth opportunities. Belanger’s analysis is in line with the overall market sentiment, showcasing a strong belief in Liquidia Technologies amid favorable market conditions and regulatory environment. The ongoing endorsement from Needham signifies a continued confidence in the company’s potential, as echoed by various analyst perspectives.

LQDA Stock Shows Strong Performance with 5.36% Increase on March 13, 2024

On March 13, 2024, LQDA stock showed strong performance, trading near the top of its 52-week range and above its 200-day simple moving average. The price of LQDA shares increased by $0.75 since the market last closed, representing a 5.36% rise. The stock closed at $14.73, showing a significant increase in value. Additionally, in after-hours trading, the stock rose by an additional $0.21. Investors and analysts may view these price movements as a sign of strength in the stock, as it continues to show growth and potential for further gains. It is important for investors to conduct thorough research and analysis before making any investment decisions.

LQDA Stock Analysis: Revenue Flat, Net Income Improves – March 13, 2024

On March 13, 2024, LQDA stock had a mixed performance based on the financial data provided by CNN Money. The total revenue for LQDA stood at $15.94 million for the past year, which remained flat compared to the previous year. However, there was a significant decrease of 23.15% in total revenue since the last quarter, with the company reporting $3.68 million in revenue for Q3.

The net income for LQDA was reported at -$41.02 million for the past year, showing a decrease of 18.61% compared to the previous year. However, there was a positive sign as the net income improved by 32.86% since the last quarter, with a reported net income of -$15.79 million for Q3.

Earnings per share (EPS) for LQDA were reported at -$0.67 for the past year, showing a slight increase of 3.35% compared to the previous year. The EPS also saw a significant improvement of 32.92% since the last quarter, with a reported EPS of -$0.24 for Q3.

Tags: LQDA
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biopharmaceutical Stock Market Today (1)

Title Poseida Therapeutics Receives Orphan Drug Designation for PBCMAALLO1 Targeting Multiple Myeloma

From Stress Relief to Sleep Improvement: Unveiling the Latest Innovations in Vagus Nerve Stimulation Devices

Cue Health NASDAQ HLTH Q4 Earnings Report Key Highlights

Automotive Trading online

Vroom Inc Q4 Financial Results Impact Stock Performance and Future Outlook

Recommended

Morningstar Stock

Shifting Tides at Morningstar: Insider Sales and Short Covering Raise Questions

4 days ago
PPL Corp Stock

PPL Corp: A Dividend Powerhouse Navigates Market Uncertainty

6 days ago
Redefining Success: How Franchises Adapt to Economic Shifts and Market Demands

Lyfts Stock Rises After Upgrade from RBC Capital

1 year ago
AI medical laboratory

Unraveling the Potential of AI in Tailoring Healthcare Solutions

2 years ago

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Cryptocurrency
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

Topics

AAL AAPL ABNB ADBE Adobe ADSK ALB AMD AMZN Apple AVGO BA C COIN Coinbase COST CRWD DELL DIS DWAC Eli Lilly EQT GM GRFS IBM INTC Intel JPM LLY META Micron MSFT NFLX NIO NVDA NVO PARA PLTR Robinhood SMCI Strategy TGT TSLA UNH VZ
No Result
View All Result

Highlights

European Approval for Nirogacestat Marks Major Milestone for SpringWorks Therapeutics

Innospec Shares Slide as Revenue Miss Overshadows Earnings Beat

Reliance Inc.: The Unassuming Titan in Metals Distribution

Abbott Laboratories Stock: Strong Earnings Mask Technical Uncertainty

NCR Voyix’s Strong Quarter Fails to Alleviate Investor Concerns

MicroStrategy’s Aggressive Bitcoin Strategy Faces Investor Scrutiny

Trending

Kraft Heinz Stock
Stocks

Kraft Heinz Stock: A Contradiction in Market Sentiment

by Dieter Jaworski
August 27, 2025
0

The investment case for consumer goods titan Kraft Heinz presents a fascinating paradox. While institutional money continues...

QuantumScape Stock

Major Investor Invesco Reduces Stake in QuantumScape Despite Breakthrough

August 27, 2025
Marcus, Millichap Stock

Major California Property Transaction Fuels Marcus & Millichap Share Rally

August 27, 2025
SpringWorks Therapeutics Stock

European Approval for Nirogacestat Marks Major Milestone for SpringWorks Therapeutics

August 27, 2025
Innospec Stock

Innospec Shares Slide as Revenue Miss Overshadows Earnings Beat

August 27, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Kraft Heinz Stock: A Contradiction in Market Sentiment August 27, 2025
  • Major Investor Invesco Reduces Stake in QuantumScape Despite Breakthrough August 27, 2025
  • Major California Property Transaction Fuels Marcus & Millichap Share Rally August 27, 2025

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Cryptocurrency
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings

© 2023 StocksToday.com